Danaher Corporation (DHR) Financials
DHR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 83.4 billion | 30.0 billion |
2023-12-31 | 84.5 billion | 31.0 billion |
2023-09-30 | 87.7 billion | 35.3 billion |
2023-06-30 | 84.9 billion | 33.2 billion |
DHR Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 1.4 billion | 60.0 million |
2023-12-31 | 1.2 billion | 26.0 million |
2023-09-30 | 1.3 billion | 92.0 million |
2023-06-30 | 1.6 billion | 109.0 million |
DHR Net Income
Date | Net Income |
---|---|
2024-03-31 | 1.1 billion |
2023-12-31 | 536.0 million |
2023-09-30 | 1.1 billion |
2023-06-30 | 1.1 billion |
DHR Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 7.0 billion | - | - |
2023-12-31 | 5.9 billion | - | 1.1 billion |
2023-09-30 | 12.3 billion | 19.5 billion | - |
2023-06-30 | 8.6 billion | 18.3 billion | - |
DHR Shares Outstanding
DHR Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 291.0 million | 368.0 million | 1.8 billion | - |
2023-12-31 | 402.0 million | 239.0 million | 766.0 million | - |
2023-09-30 | 365.0 million | 417.0 million | 2.1 billion | - |
2023-06-30 | 341.0 million | 418.0 million | 2.2 billion | - |
DHR Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 3.5 billion | 2.3 billion |
2023-12-31 | 2.7 billion | 1.1 billion |
2023-09-30 | 6.9 billion | 2.9 billion |
2023-06-30 | 7.2 billion | 3.1 billion |
DHR
List: Contenders
Price: $245.80
Dividend Yield: 0.43%
Forward Dividend Yield: 0.43%
Payout Ratio: 19.08%
Dividend Per Share: 1.08 USD
Earnings Per Share: 5.66 USD
P/E Ratio: 43.44
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1.8 million
Ebitda: 1.3 billionMarket Capitalization: 187.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 32
DGR3: 13.97%
DGR5: 12.03%
DGR10: 30.00%
DGR20: 30.00%